面向公共卫生(医疗)的细菌基因组学应用框架
本文讨论比较基因组学在医疗相关病原体(包括耐药病原体)公共卫生应用中的定位,指出临床微生物学依赖CLIA和FDA框架下的自动化平台进行快速鉴定,而公共卫生投资则侧重利用参考培养和分子方法快速检测暴发与新发耐药。作者提出结合自上而下的广泛监测与自下而上的感染及感染簇识别两种基因组学策略,覆盖从本地感染控制到区域和国家遏制及全国监测的公共卫生谱系。
要点
- 医疗相关耐药病原体遗传靶标复杂且可传播,需基因组学支撑监测。
- 临床微生物学依赖CLIA和FDA框架下的自动化平台快速鉴定病原与耐药。
- 建议结合自上而下监测与自下而上感染簇识别两种基因组学路径。
核心结论
- 对医疗相关病原体(含耐药病原体),建议在公共卫生谱系中结合自上而下与自下而上的基因组学方法,覆盖本地感染控制、区域和国家遏制及全国监测。
研究设计与样本
- 本文为述评类文章,未报告系统检索范围、样本量或研究设计细节。
主要发现
- 比较基因组学进展使医疗相关病原体的应用定义受到关注。
- 临床微生物学依赖CLIA和FDA框架下日益自动化的平台快速鉴定病原体、耐药机制和治疗选择。
- 医疗相关耐药病原体涵盖多样菌属,携带抗生素、杀生物剂和毒力决定簇等复杂遗传靶标,可高度传播。
- 美国公共卫生投资聚焦利用参考、培养和分子方法快速检测医疗相关病原体的暴发和新发耐药,这些方法分布于国家实验室网络等基础设施。
临床怎么用
- 在本地感染控制中可结合自上而下监测与自下而上感染及感染簇识别,并延伸至区域和国家遏制及全国监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advancements in comparative genomics have generated significant interest in defining applications for health care-associated pathogens. Clinical microbiology, however, relies on increasingly automated platforms to quickly identify pathogens, resistance mechanisms, and therapy options within Clinical Laboratory Improvement Amendments (CLIA)- and FDA-approved frameworks. Additionally, and most notably, health care-associated pathogens, especially those that are resistant to antibiotics, represent a diverse spectrum of genera harboring complex genetic targets, including antibiotic, biocide, and virulence determinants that can be highly transmissible and, at least for antibiotic resistance, serve as potential targets for containment efforts. U.S. public health investments have focused on rapidly detecting outbreaks and emerging resistance in health care-associated pathogens using reference, culture-based, and molecular methods that are distributed, for example, across national laboratory network infrastructures. Herein we describe the public health applications of genomic science that are built from the top-down for broad surveillance, as well as the bottom-up, starting with identification of infections and infectious clusters. For health care-associated, including antimicrobial-resistant, pathogens, we propose a combination of top-down and bottom-up genomic approaches leveraged across the public health spectrum, from local infection control, to regional and national containment efforts, to national surveillance for understanding emerging strain ecology and fitness of health care pathogens.
引用
- Halpin AL, McDonald LC, Elkins CA, et al. Framing Bacterial Genomics for Public Health (Care). J Clin Microbiol. 2021. PMID: 34076468. doi:10.1128/JCM.00135-21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。